Global Leading Market Research Publisher QYResearch announces the release of its latest report “RNAi-based Biopesticides – Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032”. For agricultural producers, crop protection executives, and agtech investors, the escalating challenges of pesticide resistance, environmental contamination, and consumer demand for residue-free food have created an urgent need for fundamentally new approaches to pest management. Traditional chemical pesticides, while effective, face diminishing returns as pest resistance spreads, while their broad-spectrum activity raises concerns about impacts on beneficial insects, soil health, and human exposure. RNAi-based biopesticides address these challenges by harnessing RNA interference (RNAi) technology to selectively silence critical genes in target pests, disrupting their growth, development, or survival with unprecedented species specificity. This report delivers a comprehensive strategic assessment of a market poised for robust double-digit growth, quantifying the value proposition that is driving investment, regulatory approvals, and commercial deployment as RNAi biopesticides emerge as a cornerstone of sustainable, precision agriculture.
Based on current situation and impact historical analysis (2021-2025) and forecast calculations (2026-2032), this report provides a comprehensive analysis of the global RNAi-based Biopesticides market, including market size, share, demand, industry development status, and forecasts for the next few years. The global market for RNAi-based Biopesticides was estimated to be worth US$ 149 million in 2025 and is projected to reach US$ 313 million, growing at a CAGR of 11.3% from 2026 to 2032. RNA interference (RNAi) is a biotechnology-based approach to developing biopesticides that achieve precise and efficient pest control by targeting key genes in pests. RNAi-based biopesticides introduce specific double-stranded RNA (dsRNA) into the pest organism, disrupting gene expression and consequently inhibiting its growth, development, or survival. This method is highly selective, affecting only the targeted pest species while minimizing impacts on non-target organisms and the environment, making it an eco-friendly solution. RNAi biopesticides have shown significant potential in controlling pests like the corn borer and cotton bollworm, offering a novel tool for resistance management.
RNA interference (RNAi) technology is gaining significant attention in agriculture as an innovative biopesticide approach. These pesticides target specific pest genes, suppressing their growth or reproduction, thereby achieving precise and efficient pest control. Compared to traditional chemical pesticides, RNAi-based biopesticides have minimal impact on the environment and non-target organisms, making them more ecologically compatible. Currently, research and applications focus on controlling pests, pathogens, and plant viruses, with notable advancements in transgenic crop development and topical application techniques. However, due to the technological complexity and stringent regulatory processes, RNAi biopesticides still have limited market penetration.
As agriculture increasingly demands sustainability and precision, RNAi biopesticides are seen as a key direction for the future of pesticide technology. Advances in more efficient RNA delivery mechanisms, improved molecular stability, and declining costs will further drive adoption. Additionally, stricter global pesticide regulations and heightened consumer concern for food safety will push the industry towards low-toxicity and high-selectivity products. Cross-disciplinary applications of RNAi in fields like bioinformatics, gene editing, and smart agriculture also open new opportunities for its development. Key drivers for RNAi biopesticides include policy support, growing market demand for green agriculture, and advancements in biotechnology. However, significant challenges remain, including high R&D costs, limitations in target specificity, poor RNA stability in the environment, and public concerns about genetic technologies. Moreover, varying acceptance levels and regulatory frameworks across different regions present additional hurdles to commercialization.
【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)】
https://www.qyresearch.com/reports/5742379/rnai-based-biopesticides
Market Trajectory: Strong Growth Anchored in Sustainability and Resistance Management
The projected 11.3% CAGR reflects a market benefiting from the convergence of escalating pest resistance to chemical pesticides, tightening environmental regulations, and the demonstrated efficacy of RNAi technology in field trials. According to recent data from the Food and Agriculture Organization (FAO) and industry analysts, global pesticide resistance has been documented in over 600 pest species, with resistance to multiple chemical classes reducing the effectiveness of conventional crop protection. Simultaneously, regulatory restrictions on chemical pesticides—including the EU’s Farm to Fork strategy and similar initiatives globally—are accelerating the search for sustainable alternatives.
Several factors are driving market expansion. The unique mode of action of RNAi biopesticides—targeting specific genes rather than broad metabolic pathways—offers a solution to chemical pesticide resistance, with no documented cross-resistance to conventional chemistries. Advances in dsRNA production, delivery mechanisms, and environmental stability have improved efficacy and reduced cost. Additionally, regulatory approvals for RNAi-based products—including the first RNAi biopesticide approved by the US EPA in 2023—have established a pathway for commercialization.
Technology Segmentation: PIP and Non-PIP
The market’s segmentation by delivery approach—PIP (Plant-Incorporated Protectant) and Non-PIP—reveals distinct product categories with different regulatory pathways and application methods.
PIP approaches involve genetically engineered crops that produce dsRNA targeting specific pests. This approach offers season-long protection but requires regulatory approval for genetically modified crops. A case study from a corn production system illustrates the value: field trials of RNAi corn targeting corn rootworm showed 95% efficacy comparable to chemical insecticides, with no detectable impact on non-target insects.
Non-PIP approaches involve topical applications of dsRNA formulations sprayed onto crops. These products offer flexibility for conventional farming systems and shorter regulatory pathways, though they face challenges in environmental stability and delivery efficiency.
Application Segmentation: Farmland, Orchard, and Other
The farmland segment encompasses row crops including corn, soybeans, and cotton, where RNAi biopesticides have demonstrated significant potential against major pests such as corn borer, soybean looper, and cotton bollworm. A case study from a corn grower illustrates the value: RNAi-based control of corn rootworm achieved equivalent yield protection to chemical insecticides while eliminating soil-applied chemical treatments.
The orchard segment includes fruit and nut crops where pest management complexity and consumer demand for residue-free produce drive interest in selective biopesticides.
Exclusive Industry Insight: The Regulatory Pathway Maturation
The defining trend shaping the RNAi-based biopesticides market is the maturation of regulatory frameworks that establish clear pathways for commercialization. Following the US EPA’s approval of the first RNAi biopesticide in 2023, regulatory agencies in Canada, Brazil, and other major agricultural markets are developing frameworks for RNAi product review. For strategic decision-makers, the RNAi-based biopesticides market presents a compelling opportunity characterized by strong growth, a unique mode of action for resistance management, and the alignment with global sustainability trends.
Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
E-mail: global@qyresearch.com
Tel: 001-626-842-1666(US)
JP: https://www.qyresearch.co.jp
